Brief: Cingulate Announces Publication Of Phase 3 Adhd Trial Results In Journal Of Child And Adolescent Psychopharmacology
30/07/2026 13:40
BRIEF-Cingulate Announces Publication Of Phase 3 Adhd Trial Results In Journal Of Child And Adolescent Psychopharmacology July 30 (Reuters) - Cingulate Inc CING.O:
CINGULATE ANNOUNCES PUBLICATION OF PHASE 3 ADHD TRIAL RESULTS IN JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
CINGULATE - CTX-1301 SHOWS STATISTICALLY SIGNIFICANT IMPROVEMENTS OVER PLACEBO IN PHASE 3 PRIMARY ENDPOINT
Source text: ID:nGNXbwRMlP
Further company coverage: CING.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cingulate
See all newsBrief: Cingulate Announces Publication Of Phase 3 Adhd Trial Results In Journal Of Child And Adolescent Psychopharmacology
NASDAQ RESUMED AT 09:39 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:34 AM
NASDAQ RESUMED AT 08:30 AM
FDA declines to approve Cingulate's ADHD treatment over manufacturing issues (updated)